Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

TY - JOUR

T1 - Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors

T2 - A Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

AU - Oechsle, K.

AU - Honecker, F.

AU - Cheng, T.

AU - Mayer, F.

AU - Czaykowski, P.

AU - Winquist, E.

AU - Wood, L.

AU - Fenner, M.

AU - Glaesener, S.

AU - Hartmann, J. T.

AU - Chi, K.

AU - Bokemeyer, C.

AU - Kollmannsberger, C.

N1 - Funding Information: Pfizer Inc., New York (investigator-initiated research grant).

PY - 2011/12

Y1 - 2011/12

KW - Angiogenesis

KW - Cisplatin resistance

KW - Germ cell tumor

KW - Relapse

KW - Sunitinib

UR - http://www.scopus.com/inward/record.url?scp=79960860865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960860865&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdr026

DO - 10.1093/annonc/mdr026

M3 - Article

C2 - 21415240

AN - SCOPUS:79960860865

SN - 0923-7534

VL - 22

SP - 2654

EP - 2660

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -